investor.ironwoodpharma.comIronwood Pharmaceuticals, Inc. - Company Overview

investor.ironwoodpharma.com Profile

Investor.ironwoodpharma.com is a subdomain of ironwoodpharma.com, which was created on 2007-10-17,making it 17 years ago. It has several subdomains, such as hip.ironwoodpharma.com , among others.

Discover investor.ironwoodpharma.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

investor.ironwoodpharma.com Information

HomePage size: 103.188 KB
Page Load Time: 0.54324 Seconds
Website IP Address: 162.159.130.11

investor.ironwoodpharma.com Similar Website

Tractor Supply Company - Company Overview
corporate.tractorsupply.com
Investor Relations :: CNS Pharmaceuticals, Inc. (CNSP)
ir.cnspharma.com
Mirum Pharmaceuticals, Inc. - Investor Relations
ir.mirumpharma.com
Multilingual Psychotherapy Centers, Inc. Jobs: Overview | Multilingual Psychotherapy Centers, Inc.
jobs.mpcipbc.com
Ironwood Counseling and Psychological Services | CarePaths EHR and Measurement Based Care
iron.carepaths.com
Rise Services, Inc. Jobs: Overview | Rise Services, Inc.
jobs.riseservicesinc.org
Ironwood HIP
hip.ironwoodpharma.com
Best Western International, Inc. Jobs: Overview | Best Western International, Inc.
jobs.bestwestern.com
CODAC Health, Recovery & Wellness Inc. Jobs: Overview | CODAC Health, Recovery & Wellness Inc.
jobs.codac.org
Momenta Pharmaceuticals, Inc. - News/Events - Overview
ir.momentapharma.com
Overview | Cyclacel Pharmaceuticals, Inc.
investor.cyclacel.com
Investors | Fusion Pharmaceuticals - Overview
ir.fusionpharma.com
Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC
lifelinepharm.tracktracerx.com
Ironwood Church | Non-Denominational Church in Mesa, AZ
gateway.redemptionaz.com
Neuropathix, Inc. – A Phyto-Medical Company | Developing Pharmaceuticals to Protect the Brain
investors.kannalife.com

investor.ironwoodpharma.com PopUrls

Ironwood Pharmaceuticals, Inc. - Company Overview
https://investor.ironwoodpharma.com/home/default.aspx
Press Releases
https://investor.ironwoodpharma.com/press-releases/default.aspx
Ironwood Pharmaceuticals, Inc. - Investor Contacts
https://investor.ironwoodpharma.com/investor-contacts/default.aspx
Why Invest
https://investor.ironwoodpharma.com/Why-Invest/default.aspx
Financials - Annual Reports
https://investor.ironwoodpharma.com/financials/annual-reports/default.aspx
Financials - Quarterly Results
https://investor.ironwoodpharma.com/financials/quarterly-results/default.aspx
Stock Information - Analyst Coverage
https://investor.ironwoodpharma.com/stock-information/analyst/default.aspx
Press Releases
https://investor.ironwoodpharma.com/press-releases/2014/default.aspx
Financials - SEC Filings
https://investor.ironwoodpharma.com/financials/sec-filings/default.aspx
Events & Presentations
https://investor.ironwoodpharma.com/events-and-presentations/default.aspx

investor.ironwoodpharma.com Httpheader

Date: Tue, 14 May 2024 06:55:15 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
CF-Ray: 8838fb467e6a5ee9-PDX
CF-Cache-Status: REVALIDATED
Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400
Strict-Transport-Security: max-age=31536000; includeSubDomains
Vary: Accept-Encoding
X-Content-Type-Options: nosniff
X-XSS-Protection: 0
Server: cloudflare

investor.ironwoodpharma.com Meta Info

content="text/html; charset=utf-8" http-equiv="Content-type"/
content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/
content="width=device-width, initial-scale=1" name="viewport"/
content="--OGiUxoB-WvaAIinUP__X6sU48peEYfvr4-iMaqNHA" name="google-site-verification"/

investor.ironwoodpharma.com Html To Plain Text

Investors Media open in a new window Contact Us open in a new window | Search open in a new window Company Science & Medicine Patients Responsibility Careers IR Home Why Invest Events & Presentations Corporate Governance Governance Documents Executive Management Board of Directors Committee Composition Annual Meeting Contact the Board Financials Quarterly Results Annual Reports SEC Filings Press Releases Investor Contacts Investor Emails Alerts RSS Feeds Stock Information Stock Quote & Chart Historical Stock Quote Analyst Coverage Investor FAQs IR Home Why Invest Events & Presentations Corporate Governance Governance Documents Executive Management Board of Directors Committee Composition Annual Meeting Contact the Board Financials Quarterly Results Annual Reports SEC Filings Press Releases Investor Contacts Investor Emails Alerts RSS Feeds Stock Information Stock Quote & Chart Historical Stock Quote Analyst Coverage Investor FAQs Close Close Investors Company Product Research & Development Patients Partnerships Careers Close Company Overview We Are Ironwood A GI-focused Healthcare Company A Leading GI Healthcare Company Corporate Overview Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years-old. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF), as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, with a site in Basel, Switzerland. Learn More28.5 Million Adult Americans may suffer from Chronic Idiopathic Constipation (CIC) 11.5 Million Adult Americans may have Irritable Bowl Syndrome with Constipation (IBS-C) ~5 Million Unique Patients since the launch of LINZESS Featured Reports View All Results Featured Events See All Events Recent News See All News Investor Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Ironwood Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates. * Required Email Address * Mailing Lists * News Events & Presentations SEC Filings End of Day Stock Quote Quarterly Reports Annual Reports Email Alert Sign Up Confirmation open in a new window Investors Media Contact us Follow us on Linkedin Follow us on Twitter COMPANY Company Overview Leadership Open Payments & Transparecy SCIENCE & MEDICINE Therapeutic Focus Pipeline Product PatientsPATIENTS Overview RESPONSIBILITY Overview Diversity, Equity & Inclusion Sustainability Safety & Compliance Patients & Research Community Giving CAREERS Working at Ironwood Internships, Co-ops & Fellowships Open Positions Copyright © Ironwood. All rights reserved Powered By Q4 Inc. 5.77.0.2 (opens in new window) Privacy Policy California Privacy PolicySite Map Terms of...

investor.ironwoodpharma.com Whois

Domain Name: IRONWOODPHARMA.COM Registry Domain ID: 1281721989_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-18T20:23:22Z Creation Date: 2007-10-17T20:40:08Z Registry Expiry Date: 2032-10-17T20:40:08Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.EASYDNS.COM Name Server: NS2.EASYDNS.COM Name Server: NS3.EASYDNS.ORG Name Server: NS6.EASYDNS.NET Name Server: REMOTE1.EASYDNS.COM Name Server: REMOTE2.EASYDNS.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:26:43Z <<<